Inicio>>Signaling Pathways>> Neuroscience>> 5-HT Receptor>>Masupirdine mesylate

Masupirdine mesylate (Synonyms: SUVN-502 mesylate)

Catalog No.GC38509

El mesilato de masupirdina (mesilato SUVN-502) es un antagonista del receptor 5-HT6 potente, selectivo, biodisponible por vÍa oral y penetrante en el cerebro (Ki de 2,04 nM para el receptor 5-HT6 humano).

Products are for research use only. Not for human use. We do not sell to patients.

Masupirdine mesylate Chemical Structure

Cas No.: 1791396-46-7

Tamaño Precio Disponibilidad Cantidad
1mg
200,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Masupirdine mesylate (SUVN-502 mesylate) is a potent, selective, orally bioavailable, and brain penetrant 5-HT6 receptor antagonist (Ki of 2.04 nM for human 5-HT6 receptor). Masupirdine mesylate (SUVN-502 mesylate) shows high selectivity over 5-HT2A receptor and other 100 target sites, and has potential for treatment of Alzheimer's disease[1].

[1]. Nirogi R, et al. Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease. J Med Chem. 2017 Mar 9;60(5):1843-1859.

Reseñas

Review for Masupirdine mesylate

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Masupirdine mesylate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.